The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 20, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Sell(S) | 9 | $8.06 | $73 |
| Sep 20, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Sell(S) | 1K | $8.18 | $10K |
| Sep 18, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 5K | — | — |
| Sep 18, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 5K | — | $0 |
| Aug 26, 2024 | Kaplan Brett | Chief Operating Officer | Grant(A) | 465K | — | $0 |
| Aug 26, 2024 | Kaplan Brett | Chief Operating Officer | Grant(A) | 78K | — | $0 |
| Jul 22, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 39K | $8.07 | $315K |
| Jul 22, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 30K | $7.98 | $239K |
| Jul 19, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 50K | $7.24 | $362K |
| Jul 19, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 10K | $7.09 | $72K |
| Jul 18, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 39K | $6.93 | $267K |
| Jul 17, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 3K | $6.91 | $22K |
| Jul 16, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 50K | $7.13 | $357K |
| Jul 15, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 42K | $7.01 | $297K |
| Jul 12, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 50K | $7.07 | $354K |
| Jul 11, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 50K | $7.11 | $356K |
| Jul 10, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 50K | $6.83 | $342K |
| Jul 9, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 6K | $6.66 | $40K |
| Jul 5, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 12K | $7.06 | $87K |
| Jul 3, 2024 | Morisset Valerie | EVP, R&D AND CSO | Sell(S) | 50K | $6.76 | $338K |
| Jul 1, 2024 | Morisset Valerie | EVP, R&D AND CSO | Option exercise(M) | 8K | — | $0 |
| Jul 1, 2024 | Morisset Valerie | EVP, R&D AND CSO | Option exercise(M) | 8K | — | $0 |
| Jun 27, 2024 | Kolchinsky Peter | Director, 10% Owner | Grant(A) | 2.5M | — | — |
| Jun 27, 2024 | Kolchinsky Peter | Director, 10% Owner | Grant(A) | 1.8M | — | — |
| Jun 27, 2024 | Kolchinsky Peter | Director, 10% Owner | Grant(A) | 973K | — | — |
| Jun 27, 2024 | Kolchinsky Peter | Director, 10% Owner | Buy(P) | 11.9M | $3.84 | $45.9M |
| Jun 27, 2024 | Kolchinsky Peter | Director, 10% Owner | Buy(P) | 1.1M | $3.84 | $4.1M |
| Jun 27, 2024 | Thomas Stephen Basil | Director | Grant(A) | 104K | — | — |
| Jun 27, 2024 | Thomas Stephen Basil | Director | Grant(A) | 100K | — | $0 |
| Jun 27, 2024 | Brennan Aoife | President and CEO, Director | Grant(A) | 550K | — | $0 |
| Jun 27, 2024 | Brennan Aoife | President and CEO, Director | Grant(A) | 275K | — | $0 |
| Jun 26, 2024 | Ratcliffe Liam | Director | Grant(A) | 10K | — | $0 |
| Jun 26, 2024 | Tate Simon | Director | Grant(A) | 10K | — | $0 |
| Jun 26, 2024 | Dunn Judith | Director | Grant(A) | 10K | — | $0 |
| Jun 26, 2024 | Rosenberg Adam Joseph | Director | Grant(A) | 10K | — | $0 |
| Jun 26, 2024 | Levin Andrew David | Executive Chairman, Director | Grant(A) | 10K | — | $0 |
| Jun 26, 2024 | Kolchinsky Peter | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| Jun 20, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Sell(S) | 1K | $7.21 | $9K |
| Jun 18, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 5K | — | — |
| Jun 18, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 5K | — | $0 |
| Apr 5, 2024 | Morisset Valerie | EVP, R&D AND CSO | Option exercise(M) | 18K | — | $0 |
| Apr 5, 2024 | Morisset Valerie | EVP, R&D AND CSO | Option exercise(M) | 18K | — | $0 |
| Mar 18, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Option exercise(M) | 40K | — | $0 |
| Sep 20, 2023 | Morisset Valerie | EVP, R&D AND CSO | Option exercise(M) | 15K | — | $0 |
| Sep 20, 2023 | Morisset Valerie | EVP, R&D AND CSO | Option exercise(M) | 5K | — | $0 |
| Sep 20, 2023 | Morisset Valerie | EVP, R&D AND CSO | Option exercise(M) | 5K | — | $0 |
| Sep 20, 2023 | Morisset Valerie | EVP, R&D AND CSO | Option exercise(M) | 15K | — | $0 |
| May 18, 2023 | RA Capital Healthcare Fund LP | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| May 18, 2023 | Levin Andrew David | Executive Chairman, Director | Grant(A) | 10K | — | $0 |
| May 18, 2023 | Rosenberg Adam Joseph | Director | Grant(A) | 10K | — | $0 |
| May 18, 2023 | Dunn Judith | Director | Grant(A) | 10K | — | $0 |
| May 18, 2023 | Ratcliffe Liam | Director | Grant(A) | 10K | — | $0 |
| May 18, 2023 | Tate Simon | Director | Grant(A) | 10K | — | $0 |
| Mar 10, 2023 | Morisset Valerie | EVP, R&D and CSO | Option exercise(M) | 255K | — | $0 |
| Mar 10, 2023 | Morisset Valerie | EVP, R&D and CSO | Option exercise(M) | 61K | — | $0 |
| Mar 10, 2023 | Morisset Valerie | EVP, R&D and CSO | Option exercise(M) | 255K | — | $0 |
| Mar 10, 2023 | Morisset Valerie | EVP, R&D and CSO | Option exercise(M) | 61K | — | $0 |
| Oct 31, 2022 | Bucher James B | EVP and General Counsel | Grant(A) | 95K | — | $0 |
| Oct 31, 2022 | Lavelle Erin | COO & CFO | Grant(A) | 170K | — | $0 |
| Oct 31, 2022 | Azelby Robert | President & CEO, Director | Grant(A) | 500K | — | $0 |
| Oct 31, 2022 | Morisset Valerie | EVP, R&D and CSO | Grant(A) | 170K | — | $0 |
| May 19, 2022 | Dunn Judith | Director | Grant(A) | 10K | — | $0 |
| May 19, 2022 | Levin Andrew David | Director | Grant(A) | 10K | — | $0 |
| May 19, 2022 | Rosenberg Adam Joseph | Director | Grant(A) | 10K | — | $0 |
| May 19, 2022 | Patterson Leone D | Director | Grant(A) | 10K | — | $0 |
| May 19, 2022 | Ratcliffe Liam | Director | Grant(A) | 10K | — | $0 |
| May 19, 2022 | Tate Simon | Director | Grant(A) | 10K | — | $0 |
| May 19, 2022 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| Jan 27, 2022 | Bucher James B | EVP and General Counsel | Grant(A) | 95K | — | $0 |
| Jan 27, 2022 | Morisset Valerie | EVP, R&D and CSO | Grant(A) | 170K | — | $0 |
| Jan 27, 2022 | Azelby Robert | President & CEO, Director | Grant(A) | 500K | — | $0 |
| Jan 27, 2022 | Lavelle Erin | COO & CFO | Grant(A) | 170K | — | $0 |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Buy(P) | 3.0M | $12.50 | $37.6M |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 1.2M | — | — |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Buy(P) | 195K | $12.50 | $2.4M |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 625K | — | — |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 4.7M | — | — |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 288K | — | — |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 518K | — | $0 |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 288K | — | $0 |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 485K | — | $0 |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 139K | — | $0 |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 2.6M | — | $0 |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 1.4M | — | $0 |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 673K | — | $0 |
| Aug 12, 2021 | RA Capital Nexus Fund II, L.P. | Director, 10% Owner | Conversion(C) | 708K | — | $0 |
| Aug 12, 2021 | Access Industries Holdings LLC | Insider | Buy(P) | 800K | $12.50 | $10.0M |
| Aug 12, 2021 | Access Industries Holdings LLC | Insider | Conversion(C) | 4.2M | — | $0 |
| Aug 12, 2021 | Access Industries Holdings LLC | Insider | Conversion(C) | 641K | — | $0 |
| Aug 12, 2021 | Access Industries Holdings LLC | Insider | Conversion(C) | 3.6M | — | $0 |
| Aug 9, 2021 | Kolchinsky Peter | Director, 10% Owner | Grant(A) | 20K | — | $0 |
| Aug 9, 2021 | Levin Andrew David | Director | Grant(A) | 20K | — | $0 |
| Aug 9, 2021 | Tate Simon | Director | Grant(A) | 20K | — | $0 |
| Aug 9, 2021 | Rosenberg Adam Joseph | Director | Grant(A) | 20K | — | $0 |
| Aug 9, 2021 | Ratcliffe Liam | Director | Grant(A) | 20K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).